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Summary  Emerging  picture  of  hantavirus  infection  in  the  South  America  is  charac-
terized  by  greater  proportion  of  childhood  infection  and  wider  spectrum  of  disease
from  mild  asymptomatic  to  lethal  cardiopulmonary  disease.  Barbados  is  endemic  for
dengue  and  leptospirosis,  both  of  which  share  clinical  features  with  hantavirus  infec-
tion  and  in  many  cases  neither  of  these  diagnosis  could  be  conﬁrmed.  We  investigate
whether  some  of  the  children  hospitalized  with  suspected  dengue  could  indeed
have  been  hantavirus  infections.  In  this  prospective  study  children  hospitalized  with
suspected  dengue  were  tested  for  hantavirus  infection  using  ELISA  for  the  IgM  anti-
bodies.  Thirty-eight  children  tested  positive  for  hantavirus  infection.  They  presented
with  fever,  headache  and  mild  respiratory  and  gastrointestinal  symptoms  and  signs.
None  of  them  had  features  suggestive  of  hantavirus  cardiopulmonary  syndrome.
Blood  count  values  ranged  from  low  to  normal  to  high  for  their  age.  There  were  no
deaths.  Hantavirus  infection  is  prevalent  in  this  Caribbean  country.  It  predominantly
presents  with  milder  disease  and  is  responsible  for  some  of  the  nonspeciﬁc  febrile
illnesses  in  children.
© 2015  King  Saud  Bin  Abdulaziz  University  for  Health  Sciences.  Published  by  Elsevier
Limited.  All  rights  reserved.∗ Corresponding author at: Faculty of Medical Sciences, UWI
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itted from  rodents  to  humans  are  known  to  cause
 major,  sometimes  overlapping  clinical  syndromes
1—3]. In  Europe  and  in  Asia  several  species  of
nces. Published by Elsevier Limited. All rights reserved.
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hantavirus,  referred  to  as  the  old  world  hantavirus
causes a  syndrome  characterized  by  hemorrhagic
fever with  renal  syndrome  (HFRS)  [2,3].  In  1993,
a new  syndrome  caused  by  the  hantavirus  and
characterized by  a  febrile  prodrome  and  rapidly
progressive pulmonary  edema  and  shock  was  recog-
nized [1,3,4].  This  syndrome  was  called  the  Hanta
Pulmonary  Syndrome  or  the  hantavirus  cardiopul-
monary syndrome  (HCPS).  Since  the  1993,  similar
pulmonary  syndromes  have  been  associated  with
Sin Nombre  virus  (SN)  and  other  species  of  han-
tavirus  in  many  of  the  North  and  South  American
countries [5—8]. With  further  characterization  of
the hantavirus  infection  in  the  Americas,  based  on
some small  studies,  certain  notable  differences  in
the hantavirus  infection  in  the  North  and  South
America have  been  reported  [5—8]. The  emerg-
ing picture  of  the  hantavirus  infection  in  South
America is  characterized  by  possible  person  to  per-
son transmission,  greater  proportion  of  childhood
infections and  wide  spectrum  of  disease  from  mild
asymptomatic  diseases  to  lethal  pulmonary  disease
typical of  the  HCPS  [6,7,9].
Barbados,  one  of  the  Caribbean  islands,  in
close proximity  to  North  and  South  America  is
endemic for  dengue  transmitted  by  Aedes  aegypti
mosquitoes and  Leptospirosis  transmitted  by  the
rodents [10].  Dengue  is  known  to  have  nonspeciﬁc
presentations  shared  by  other  infections  such  as
hantavirus,  Inﬂuenza  virus,  Leptospirosis  and  Rick-
ettsia.
Objectives
In this  study  we  asked  the  question  whether  some
of the  suspected  dengue  cases  where  dengue  was
not conﬁrmed  could  indeed  have  been  hantavirus
infection [11—14].  We  also  studied  the  clinical  and
laboratory  features  of  the  conﬁrmed  hantavirus
infection to  see  if  they  can  provide  clues  to  the
early diagnosis  of  this  infection.
Methods
Study design
This  is  a  prospective  study.  This  study  was  con-
ducted at  the  Queen  Elizabeth  Hospital  (QEH),
which is  the  only  hospital  with  admitting  facility
for children  in  Barbados,  from  October  2009  to
September  2011.  This  study  forms  a  part  of  the
ongoing Barbados  dengue  study.  The  study  included
all febrile  children  admitted  to  the  QEH  and  who
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ad  a  positive  hantavirus  IgM  antibody  titer.  Pres-
nce of  IgM  antibodies  in  the  acute  phase  serum  was
onsidered  diagnostic  of  hantavirus  infection  [15].
tudy subjects
hildren,  who  are  admitted  to  the  QEH  with  sus-
ected  dengue,  are  attended  by  pediatricians.  They
eceive standard  supportive  care.  They  are  rou-
inely tested  for  dengue  IgM  titers.  Blood  samples
or serology  were  obtained  on  day  3—7  of  the  ill-
ess. All  other  blood  tests  are  routinely  done  at  the
ime of  admission  and  repeated  as  necessary.  All
reatments,  investigation  results,  discharge  date
nd diagnosis  are  recorded  in  the  patient’s  ﬁle.
aboratory methods
engue  diagnostic  techniques  have  been  discussed
n an  earlier  published  study  [9].  During  the  study
eriod,  the  samples  that  were  submitted  for  the
engue  IgM  &  IgG  titers  were  also  tested  for  the
antavirus IgM  titers  if they  were  found  to  be  neg-
tive for  the  dengue  IgM.  Not  all  the  dengue  IgM
egative  samples  could  be  tested  due  to  periodic
ut of  stock  for  the  reagents.  Hantavirus  testing
as performed  by  enzyme  linked  immunosorbent
ssay (ELISA)  using  the  Focus  Diagnostics  kits  (IgM
nd IgG  DxSelect® CA,  USA).  It  detects  antibodies  to
ve predominant  strains  including  Hantaan  (HTN),
uumala  (PUU),  Dobrava  (DOB),  Seoul  (SEO)  and
in Nombre  (SN).  The  IgM  test  is  reported  to  have
n overall  sensitivity  of  95.1%  (83.5—99.4%)  and  a
peciﬁcity of  94.1%  (83.8—98.8%)  [16]. The  testing
rocedure  was  performed  according  to  the  man-
facturer’s instructions.  Based  on  the  published
uidelines from  the  CDC  &  PAHO,  detection  of  IgM
ntibodies  in  the  patient’s  serum  was  taken  as  evi-
ence of  recent  hantavirus  infection  [15]. Both  the
engue tests  and  the  hantavirus  tests  were  done
t the  Public  Health  Laboratory  of  the  Ministry
f Health,  Barbados.  Full  blood  counts  and  kidney
unction  tests  are  routinely  done  on  all  admit-
ed febrile  children.  Other  investigations  such  as
eptospira serology,  liver  function  tests  and  chest
adiograph  were  ordered  when  indicated.
Files  of  all  the  children  admitted  to  the  QEH
ith febrile  illness  and  who  tested  positive  for
antavirus infection  were  reviewed.  Data  were
xtracted  into  a  predesigned  structured  data  col-
ection sheet  and  included  demographic  data,  date
f onset  of  illness,  duration  of  symptoms  at  the  pre-
entation, symptoms  and  signs  on  presentation  to
he hospital,  results  from  the  investigations,  course
f the  illness  during  the  hospital  stay,  duration  of
ospital stay  and  the  outcome.  Patients  name  was
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Table  1  Basic  demography  of  hospitalized  children
with  hantavirus  infection.
No.  %  (95%  conﬁdence  interval)
Gender
Female  17  44.7  (29.0—61.5)
Male  21  55.3  (38.5—71.0)
Age  group  (years)
0—<5 17 44.7  (29.0—61.5)
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xcluded  from  the  data  collection  sheet  and  the
omputer  database  and  a  pre-assigned  code  was
sed for  identiﬁcation  instead.
tatistics
ll  the  data  extracted  from  the  patient’s  chart  were
ntered  into  a  Microsoft  Access® data  sheet  for
nalysis. Microsoft  Excel® was  used  for  the  gener-
tion of  tables  and  graphs.  95%  conﬁdence  interval
as calculated  for  all  proportions  and  Chi  square
est  were  applied  to  test  for  all  categorical  vari-
bles.  A  P  value  of  <0.05  was  taken  as  signiﬁcant.
esults
uring  the  2  years  study  period,  there  were  672
hildren with  suspected  dengue  where  a  blood  sam-
le were  sent  for  dengue  serology  testing.  Of  these
amples,  272  were  also  tested  for  hantavirus.  There
ere 38  (22.1%,  95%  CI  —  16.3%,  29.2%)  who  tested
ositive (IgM)  for  hantavirus  infection.  All  38  chil-
ren were  negative  for  dengue  IgM  antibodies.  The
ean duration  of  the  febrile  illness  at  the  time
f admission  to  the  hospital  was  2.6  days  (range
—5 days).  The  basic  demographic  data  is shown  in
able  1.  The  median  age  of  the  cases  was  60  months
age range  7 months  to  181  months).  Overall,  45%
95% CI  = 29—62%)  of  all  the  diagnosed  cases  of  han-
avirus  infections  were  in  children  under  5  years.
owever, this  difference  in  the  age  distribution  of
d
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Figure  1  Seasonal  distribution  of  h5—<10 14  36.8  (22.3—54.0)
10—<15 7  18.4  (8.3—34.9)
hildren  with  hantavirus  infection  was  not  statisti-
ally signiﬁcant  (P =  0.22).  Majority  (92%)  of  these
hildren  were  of  Afro-Caribbean  decent.  Seasonal
istribution of  the  cases  of hantavirus  infection  is
hown in  Fig.  1.
Clinical  presentations  at  the  time  of  admission
o the  hospital  for  all  of  the  hantavirus  infected
hildren are  shown  in  Table  1.  All  38  children
ad fever  as  a  presenting  feature.  Overall  26.3%
95% CI  =  12.1—40.6)  of  children  with  conﬁrmed
antavirus infection  presented  predominantly  with
ild respiratory  symptoms  and  signs.  Almost,  an
qual proportion  (23.7%;  95%  CI  =  13.9—43.4)  of
antavirus  infected  children  presented  with  gastro-
ntestinal  symptoms  and  signs  including  vomiting
nd diarrhea.  The  remaining  50%  presented  pre-
ominantly  with  fever  along  with  other  nonspeciﬁc
ymptoms and  signs  such  as  headache  (31.6%;  95%
I = 18.0—48.8).  Bleeding  manifestations  were  seen
n 4 cases  (10.5%;  95%  CI  =  3.4—25.8).  Two  children
antavirus  infection  in  children.
84  A.  Kumar  et  al.
Table  2  Clinical  presentation  in  hanta  infections.
Clinical  presentation  N  %  (95%  CI)
Respiratory  (one  or  more  of  the  followings)  —  cough,  running
nose,  tachypnea
9 23  (12.1—40.6)
Gastrointestinal  (one  or  more  of  the  followings)  —  vomiting,
diarrhea
10 26  (13.9—43.4)
Headache  12  31.6  (18.0—48.8)
Arthralgia,  myalgia 5  13.1 (4.9—28.9)
Lymphadenopathy 3  7.9 (2.1—22.5)
Bleeding  manifestations 4  10.5 (3.4—25.8)
Syncope/hypotension  3  7.9  (2.1—22.5)
Seizures  2  5.3  (0.9—19.7)
Jaundice  1  2.6  (0.1—15.4)
Rash  1  2.6  (0.1—15.4)
Table  3  Laboratory  ﬁndings  in  children  with  hantavirus  infection.
Lab-result  Low  Normal  High  Mean  Median  Min  Max  Std.  dev.
Leucocytes  ×  103/ml <6  6—12  >127  (18.9%)  18  (48.6%)  12  (32.4%)  10.97  9  2  31  6.89
Platelets  ×  103/ml <150  150—450 >4508  (21.6%) 23  (62.2%) 6  (16.2%) 268  235  28  585  147
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31  (83.8%)  
had  minimal  upper  gastrointestinal  bleed  (both
these children  had  vomiting)  combined  with  either
nose bleeding  or  gum  bleeding  (Table  2).
Because the  result  of  the  hantavirus  IgM  anti-
bodies was  not  known  until  after  the  patients  were
discharged  from  the  hospital  the  38  febrile  chil-
dren who  subsequent  tested  positive  for  hanta
infection, had  various  discharge  diagnosis.  Viral
illness was  the  discharge  diagnoses  in  14  (36.8%;
95% CI  =  22.3—54.03)  cases.  Among  children  5  years
or younger,  viral  illness  accounted  for  52.9%  (95%
CI =  28.5—76.1)  and  among  the  children  older  than
5 years  it  accounted  for  33.3%  (95%  CI  =  15.5—56.9)
of all  discharge  diagnoses.  Upper  respiratory
tract infection  was  the  discharge  diagnoses  in  6
cases (15.8%;  95%  CI  =  6.6—31.9).  Four  of  these
cases were  children  5  years  or  younger  in  age.
Other discharge  diagnosis  included  Acute  Viral
Gastritis/Gastroenteritis  in  6  cases  (15.8%;  95%
CI =  6.6—31.9),  dengue  was  the  discharge  diagnose
in 6  cases  (15.8%;  95%  CI  =  6.6—31.9).  The  diagno-
sis of  Lower  Respiratory  tract  Infection  in  4 cases
(10.5%;  95%  CI  =  3.4—25.8).
Laboratory  results  were  documented  in  37  cases
that were  conﬁrmed  to  have  hantavirus  infection
(Table  3).  Twelve  (32.4%;  95%  CI  =  18.5—49.9)  chil-
dren had  a  counts  higher  than  12  × 103/ml,  while
7 (18.9%;  95%  CI  =  8.6—35.7)  had  a  counts  less  than
6 ×  103/ml.  Eight  (21.6%;  95%  CI  = 10.4—38.7)  had
v
c
e
l (16.2%)  45.77  40  17  178  27.78
 count  that  was  less  than  150  ×  103/ml.  Six  chil-
ren (16.2%;  95%  CI  =  6.8—32.7)  had  a  creatinine
alue that  was  above  the  normal  reference  value
>60 mol/l)  for  children.  Aspartate  transaminase
as raised  in  two  cases  above  the  upper  limit  of
he normal  range  for  their  age;  both  these  children
ere older  than  5  years  and  because  of  the  raised
iver enzymes  had  dengue  with  hepatitis  as  their
ischarge  diagnosis.
None  of  the  38  children  required  pediatric  inten-
ive care  and  there  were  no  deaths.  The  Median
uration of  hospitalization  was  3 days  (range  1—5
ays) and  there  were  no  in-hospital  complications
oted in  any  of  the  38  cases.
iscussion
he  ﬁrst  pathogenic  New  World  hantavirus  (Sin
ombre  virus)  was  discovered  in  the  early  1990s  in
he Four  Corners  region  of  the  United  States  [1,4].
rom this  time  on,  numerous  additional  pathogenic
ew World  hantaviruses  were  identiﬁed  and  char-
cterized  including  Sin  Nombre  Virus,  Andes  virus,
lack Creek  Canal  virus,  Choclo  virus,  New  York
irus and  others.  New  World  hantaviruses  are  the
ausative  agent  of  approximately  300  cases  of  HPS
ach year  in  North  and  South  America,  with  letha-
ity rates  up  to  50%  [3,5—8,17,18].
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In  this  ﬁrst  report  of  hantavirus  infection  in
he Caribbean,  we  describe  a  series  of  38  cases
etected on  screening  of  serum  obtained  from
hildren (<16  years)  suspected  to  have  dengue.
ver ﬁve  percent  of  those  tested  for  hantavirus
rom among  children  suspected  to  have  dengue  and
ested negative  for  dengue  had  hantavirus  infec-
ion. It  is  well  documented  that  the  Caribbean
egion including  Barbados  is  endemic  for  dengue
ith occurrence  of  dengue  in  increasing  numbers
ver the  past  years  [10,19].  In  a  recent  study  from
arbados,  it  was  shown  that  over  half  of  all  sus-
ected  childhood  cases  of  dengue  tested  negative
or both  the  cell  culture  of  the  virus  or  tested  neg-
tive for  the  NS1  antigen  in  blood  sample  taken
uring the  ﬁrst  5  days  of  the  illness,  as  well  as  the
engue  IgM  antibodies  in  serum  sample  taken  dur-
ng day  5—14  of  the  illness  [10].  This  raised  the
ossibility of  other  potential  etiological  agent  in
hese cases.  The  ﬁndings  from  this  study  for  the  ﬁrst
ime has  clearly  shown  that  many  of  these  cases  in
hildren  that  presents  as  febrile  illnesses  and  sus-
ected to  have  dengue  are  due  to  the  hantavirus
nfection. Similar  ﬁndings  were  reported  in  another
ecent  study  from  Indonesia  [14]. The  endemicity
f the  rodent  born  zoonosis  Leptospirosis  in  this
ountry  also  lends  support  to  the  ﬁndings  from
his study  [20—26]. Interesting  as  early  as  2002,
roen et  al.  had  reported  serological  evidence
f hantavirus  in  humans  and  rodents  in  Barbados
27].
Most of  the  hantavirus  cases  from  the  Americas
s well  as  those  from  Asia  and  Europe  have  been
eported in  adults  [3,28,29].  There  are  only  a  small
umber of  studies  reporting  hantavirus  infection  in
hildren [9,32,33].  Over  half  of  all  cases  in  this
eries  were  in  the  age  group  less  than  ten  years
ith median  age  of  5 years  (age  range  7 months
o 181  months).  In  the  report  from  USA  the  age
ange for  the  infected  children  was  from  10  to  16
ears [33]. As  noted  earlier  serological  evidence  of
antavirus  transmission  in  this  country  was  docu-
ented  as  early  as  the  late  nineties  [27]. Infections
oted at  younger  age  in  this  study  may  reﬂect  a
hanging  epidemiology  of  hantavirus.  It  would  be
nteresting  to  study  the  incidence  of  the  hantavirus
nfection among  the  adult  population  in  this  coun-
ry. Another  interesting  epidemiological  ﬁnding  in
his series  was  a  near  equal  male  to  female  ratio.
n the  published  literature  nearly  two-thirds  of  all
ases were  males  [28—31].  However,  of  note,  all
f these  reports  are  based  on  studies  that  have
dult cases  and  this  ratio  may  be  related  to  occu-
ational exposure  [28—31]. The  ﬁndings  from  this
tudy  highlight  the  role  of  hantavirus  as  an  emerging
nfectious  disease  in  children.
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In  this  country  cases  of  conﬁrmed  hantavirus
nfections peaked  during  the  rainy  months  of June
hrough October.  Similar  seasonal  pattern  have
een reported  in  several  other  countries  from  the
mericas [13,29,34].
In the  published  literature,  new  world  hantavirus
s known  to  cause  a  serious  form  the  HCPS  which
arries a high  mortality.  In  this  series,  majority
f the  children  had  milder  form  of  the  disease
anifesting with  either  nonspeciﬁc  febrile  illness
ithout  any  localizing  symptoms  or  with  respiratory
nd/or gastrointestinal  symptoms.  Of  note,  many
f these  symptoms  and  signs  have  been  reported
n the  prodromal  and  early  period  of  the  HCPS  in
everal  studies  from  the  Americas  [6—8]. Less  than
ne-eighth  of  cases  had  potentially  serious  man-
festations  such  as  bleeding  and/or  hypotension.
lso, less  than  a third  of  cases  had  leukocytosis
nd/or thrombocytopenia.  None  of  our  cases  had
ulmonary  edema  and/or  myocardial  depression.
hese are  reported  to  be  the  typical  manifesta-
ions of  the  HSPC  in  many  studies  [6—8]. None
f our  cases  met  the  diagnostic  criteria  for  HCPS
6—8]. The  classical  manifestation  of  the  new  world
antavirus  infections  from  the  Americas  has  been
escribed  as  the  HPCS.  However,  recent  studies
rom different  regions  have  reported  mortality
ates varying  from  as  high  as  60%  to  as  low  as  11%
7,34].  Some  recent  studies  from  south  America
ave reported  milder  forms  of  the  disease  espe-
ially in  children  [8,35]. The  clinical  manifestations
f the  hantavirus  infection  seen  in  this  setting
re similar  to  those  of  the  Andes  virus  infection
eported from  the  south  America  than  those  of  the
N virus  infection  reported  from  the  north  Amer-
ca [35]. Also,  there  are  studies  from  Americas
hich have  reported  acute  SN  infection  without
ulmonary syndrome  [36]. It is  possible  that  less
irulent  hantaviruses  are  responsible  for  the  mild
nd subclinical  illnesses  circulating  in  this  region
37,38]. A  great  deal  of  genetic  diversity  of  han-
avirus  in the  Americas  has  been  reported  [6]. It
s noteworthy,  none  of  the  rodent  hosts  of han-
aviruses that  are  associated  with  the  HCPS  are
ound in  Barbados  [39]. The  Norway  rat  (Rattus
orvegicus), Black  rat  (Rattus  rattus)  and  the  House
ouse (Mus  muscus)  are  the  most  common  rodent
pecies found  in  Barbados  [40]. It  is  possible  that
hey are  carrier  to  hantavirus  species  that  cause
ilder  disease.onclusions
n  summary,  ﬁndings  from  this  study  have,  for
he ﬁrst  time,  documented  the  prevalence  of
[[
[
[
[
[
[
[86  
hantavirus  infection  in  this  English  speaking
Caribbean country.  The  clinical  manifestations  of
the hantavirus  infection  in  this  country  is  predomi-
nantly  milder  disease  not  reported  in  the  published
literature. At  least,  some  of  the  cases  of  febrile
illnesses in  children  with  or  without  respiratory
and gastrointestinal  symptoms  and  signs  are  due
to hantavirus  infection.  There  is  a need  for  larger
studies  including  adult  population  from  this  country
and from  the  wider  Caribbean  to  substantiate  the
ﬁndings from  this  study,  to  establish  the  prevalent
serotypes of  hantavirus  in  this  region  and  to  ascer-
tain the  likelihood  of  potentially  severe  disease
forms resulting  in  lethal  cardio-pulmonary  involve-
ment.
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